Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxaliplatin Phase II Trial in Association With 5FU and Folinic Acid in the Treatment of Advanced Unresectable or Metastatic Gastric Cancer.

NCT00263354 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00263354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxaliplatin Phase II Trial in Association With 5FU and Folinic Acid in the Treatment of Advanced Unresectable or Metastatic Gastric Cancer.
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
July 31, 2006
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasms